NUVB
Nuvation Bio Inc.
Key Financials
Net Income
$-204627000
↑ 64.0%
Gross Profit
$795000
↑ Infinity%
Operating Income
$-213064000
↑ 64.0%
Total Assets
$594.8M
↑ 10.0%
Revenue
$62.9M
↑ 699.0%
Shareholders' Equity
$305.7M
↓ 34.1%
EPS (Diluted)
$-0.60
↑ 71.6%
Total Liabilities
$289.1M
↑ 276.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 6/30/2026 | View on SEC |
| 424B5 | 6/29/2026 | View on SEC |
| 305B2 | 6/29/2026 | View on SEC |
| FWP | 6/26/2026 | View on SEC |
| 424B5 | 6/25/2026 | View on SEC |
| 4 | 6/24/2026 | View on SEC |
| 4 | 6/24/2026 | View on SEC |
| 4 | 6/24/2026 | View on SEC |
| 144 | 6/23/2026 | View on SEC |
| 144 | 6/23/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NUVB |
| Company Name | Nuvation Bio Inc. |
| CIK | 1811063 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 332-208-6102 |